chrX-18507109-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001323289.2(CDKL5):āc.13A>Gā(p.Asn5Asp) variant causes a missense change. The variant allele was found at a frequency of 0.0000025 in 1,197,743 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.0000090 ( 0 hom., 0 hem., cov: 23)
Exomes š: 0.0000018 ( 0 hom. 1 hem. )
Consequence
CDKL5
NM_001323289.2 missense
NM_001323289.2 missense
Scores
4
13
Clinical Significance
Conservation
PhyloP100: 5.55
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.11637953).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDKL5 | NM_001323289.2 | c.13A>G | p.Asn5Asp | missense_variant | 2/18 | ENST00000623535.2 | |
CDKL5 | NM_001037343.2 | c.13A>G | p.Asn5Asp | missense_variant | 3/22 | ||
CDKL5 | NM_003159.3 | c.13A>G | p.Asn5Asp | missense_variant | 2/21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDKL5 | ENST00000623535.2 | c.13A>G | p.Asn5Asp | missense_variant | 2/18 | 1 | NM_001323289.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000898 AC: 1AN: 111357Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33535
GnomAD3 genomes
AF:
AC:
1
AN:
111357
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33535
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000546 AC: 1AN: 183249Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67709
GnomAD3 exomes
AF:
AC:
1
AN:
183249
Hom.:
AF XY:
AC XY:
0
AN XY:
67709
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000184 AC: 2AN: 1086333Hom.: 0 Cov.: 26 AF XY: 0.00000283 AC XY: 1AN XY: 352785
GnomAD4 exome
AF:
AC:
2
AN:
1086333
Hom.:
Cov.:
26
AF XY:
AC XY:
1
AN XY:
352785
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000898 AC: 1AN: 111410Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33598
GnomAD4 genome
AF:
AC:
1
AN:
111410
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33598
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 15, 2016 | A variant of uncertain significance has been identified in the CDKL5 gene. The N5D variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations and it was not observed with any significant frequency in the 1000 Genomes Project. The N5D variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species. However, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. - |
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Dec 15, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CDKL5 protein function. ClinVar contains an entry for this variant (Variation ID: 421693). This missense change has been observed in individual(s) with CDKL5-related conditions (PMID: 29264392). This variant is present in population databases (rs767844474, gnomAD 0.008%). This sequence change replaces asparagine, which is neutral and polar, with aspartic acid, which is acidic and polar, at codon 5 of the CDKL5 protein (p.Asn5Asp). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.;T;T;.;.;.;.
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;D;D;D;.;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;.;N;.;.;.;.;N
MutationTaster
Benign
N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;.;N;.;.;.;.;.
REVEL
Benign
Sift
Benign
T;.;.;T;.;.;.;.;.
Sift4G
Benign
T;.;.;T;.;T;T;T;T
Polyphen
B;.;.;B;.;.;.;.;.
Vest4
MutPred
Gain of ubiquitination at G2 (P = 0.0337);Gain of ubiquitination at G2 (P = 0.0337);Gain of ubiquitination at G2 (P = 0.0337);Gain of ubiquitination at G2 (P = 0.0337);Gain of ubiquitination at G2 (P = 0.0337);Gain of ubiquitination at G2 (P = 0.0337);Gain of ubiquitination at G2 (P = 0.0337);Gain of ubiquitination at G2 (P = 0.0337);Gain of ubiquitination at G2 (P = 0.0337);
MVP
MPC
1.9
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at